Allegis Investment Advisors’s Novartis NVS Stock Holding History

Allegis Investment Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$506K	Buy	6,988 +248	+4%	+$18.9K	0.16%	136
2017 Q4	$507K	Buy	6,740 +2,162	+47%	+$163K	0.15%	151
2017 Q3	$352K	Buy	4,578 +1,197	+35%	+$90.4K	0.08%	193
2017 Q2	$253K	Buy	+3,381	New	+$240K	0.06%	213
2016 Q1	–	Sell	-613	Closed	-$47K	–	684
2015 Q4	$47K	Buy	+613	New	+$48.7K	0.03%	346

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Allegis Investment Advisors's NVS Position: Q1 2018 in Review

Allegis Investment Advisors increased its Novartis (NVS) stake by 3.7% in Q1 2018, buying an estimated $18.9K and bringing the position to 6,988 shares worth $506K. The position accounts for 0.16% of the portfolio, ranked #136.

Allegis Investment Advisors first reported a position in NVS in Q4 2015 and has held it in 5 quarters since. The position peaked at $507K in Q4 2017. 1,013 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

Allegis Investment Advisors held 6,988 shares of Novartis worth $506K as of Q1 2018.
Allegis Investment Advisors bought 248 Novartis shares in Q1 2018, an estimated $18.9K.
Novartis made up 0.16% of Allegis Investment Advisors's portfolio in Q1 2018, its #136 holding.
Allegis Investment Advisors first reported a position in Novartis in Q4 2015 and has held it in 5 quarters since.
Allegis Investment Advisors's Novartis position peaked at $507K in Q4 2017.
1,013 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on Allegis Investment Advisors's 13F filing for Q1 2018, filed 24 Apr 2018.